1. Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction. Issue 19 (21st April 2017) Authors: Holte, Espen; Kleveland, Ola; Ueland, Thor; Kunszt, Gabor; Bratlie, Marte; Broch, Kaspar; Michelsen, Annika E; Bendz, Bjørn; Amundsen, Brage H; Aakhus, Svend; Damås, Jan Kristian; Gullestad, Lars; Aukrust, Pål; Wiseth, Rune Journal: Heart Issue: Volume 103:Issue 19(2017) Page Start: 1521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction. (15th November 2018) Authors: Kleveland, Ola; Ueland, Thor; Kunszt, Gabor; Bratlie, Marte; Yndestad, Arne; Broch, Kaspar; Holte, Espen; Ryan, Liv; Amundsen, Brage H.; Bendz, Bjørn; Aakhus, Svend; Espevik, Terje; Halvorsen, Bente; Mollnes, Tom E.; Wiseth, Rune; Gullestad, Lars; Aukrust, Pål; Damås, Jan Kristian Journal: International journal of cardiology Issue: Volume 271(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Novel Insights Into the Effects of Interleukin 6 Antagonism in Non–ST‐Segment–Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform. Issue 12 (16th June 2020) Authors: George, Marc J.; Kleveland, Ola; Garcia‐Hernandez, Jorge; Palmen, Jutta; Lovering, Ruth; Wiseth, Rune; Aukrust, Pål; Engmann, Jorgen; Damås, Jan Kristian; Hingorani, Aroon D.; Gullestad, Lars; Casas, Juan P.; Ueland, Thor Journal: Journal of the American Heart Association Issue: Volume 9:Issue 12(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI). Issue 2 (15th October 2019) Authors: Anstensrud, Anne Kristine; Woxholt, Sindre; Sharma, Kapil; Broch, Kaspar; Bendz, Bjørn; Aakhus, Svend; Ueland, Thor; Amundsen, Brage H; Damås, Jan Kristian; Hopp, Einar; Kleveland, Ola; Stensæth, Knut Haakon; Opdahl, Anders; Kløw, Nils-Einar; Seljeflot, Ingebjørg; Andersen, Geir Øystein; Wiseth, ... Journal: Open heart Issue: Volume 6:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction. (1st January 2019) Authors: Ueland, Thor; Kleveland, Ola; Michelsen, Annika E.; Wiseth, Rune; Damås, Jan Kristian; Holven, Kirsten B.; Aukrust, Pål; Gullestad, Lars; Yndestad, Arne; Halvorsen, Bente Journal: International journal of cardiology Issue: Volume 274(2019) Page Start: 348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction. Issue 2 (18th September 2018) Authors: Ueland, Thor; Kleveland, Ola; Michelsen, Annika E; Wiseth, Rune; Damås, Jan Kristian; Aukrust, Pål; Gullestad, Lars; Halvorsen, Bente; Yndestad, Arne Journal: Open heart Issue: Volume 5:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The IL-6 receptor inhibitor tocilizumab attenuated expression of C5a receptor 1 and 2 in patients with myocardial infarction. (September 2017) Authors: Orrem, Hilde L.; Nilsson, Per H.; Pischke, Søren E.; Kleveland, Ola; Ekholt, Karin; Aukrust, Pål; Halvorsen, Bente; Gullestad, Lars; Barratt-Due, Andreas; Mollnes, Tom E. Journal: Molecular immunology Issue: Volume 89(2017:Sep.) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction. Issue 1 (10th May 2021) Authors: Helseth, Ragnhild; Kleveland, Ola; Ueland, Thor; Wiseth, Rune; Damas, Jan Kristian; Broch, Kaspar; Michelsen, Annika; Bendz, Bjørn; Gullestad, Lars; Aukrust, Pål; Seljeflot, Ingebjørg Journal: Open heart Issue: Volume 8:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗